期刊文献+

25例冠状动脉支架内血栓患者临床分析 被引量:3

原文传递
导出
摘要 目的 探讨经皮冠状动脉介入治疗(PCI)术后支架内血栓患者的临床特点、影响因素及治疗效果.方法 回顾性分析本院心内科冠心病患者支架置入术(共3854例)后发生支架内血栓患者(25例)的临床特点、冠状动脉造影及治疗情况.结果 25例支架内血栓患者中急性心肌梗死25例(100%),多支血管病变22例(88%),合并大量吸烟史14例(56%),高脂血症13例(52%),高血压病11例(44%),糖尿病11例(44%).血栓靶血管累及左前降支16例,血栓靶血管为小血管(直径:<2.5 mm)11例,长病变(>20 mm)15例.18例患者经介入干预后血流达TIMI 3级;7例血流达TIMI 1-2级.25例患者均存活出院.结论 支架内血栓形成多发生于急性心肌梗死、多支血管病变、大量吸烟、前降支病变、小血管(直径<2.5mm)、长病变(>20 mm)、抗血小板治疗不充分等.急诊尽早再次介入治疗是治疗支架内血栓形成的首选治疗方案.
出处 《中国医师杂志》 CAS 2011年第3期346-348,共3页 Journal of Chinese Physician
  • 相关文献

参考文献15

  • 1郭志福,郑兴,秦永文.药物洗脱支架内血栓形成研究进展[J].介入放射学杂志,2007,16(8):568-571. 被引量:8
  • 2Luscher TF,Steffel J,Eberli FR,et al.Drug 2 eluting stent and coronary thrombosis:biological mechanisms and clinical imp lications.Circulation,2007,115(8):105-108.
  • 3Lscher TF,Steffel J,Eberli FR,et al.Drug-eluting stent and coronary thrombosis:biological mechanisms and clinical implications.Circulation,2007,115(8):1051-1058.
  • 4DE La Torre-Hem NDEZ JM,Alfonso F,Hem NDEZ F,et al.Drug-eluting stent thrombosis:results from the multicenter Spanish registry ESTROFA.J Am Coll Cardiol,2008,51(10):986-990.
  • 5Vats HS,Hocking WG,Rezkalla SH.Suspected clopidogrel resistance in a patient with acute stent thrombosis.Nat Clin Pract Cardiovasc Med,2006,3(4):226-230.
  • 6Urban P,Gershlick AH,Guagliumi G,et al.Safety of coronary sirolimus-eluting stents in daily clinical practice:one-year followup of the e-Cypher registry.Circulation,2006,113(11):1434-1441.
  • 7曲海波,李占全,高阳,张明,袁龙.冠状动脉药物洗脱支架内顽固性亚急性血栓形成一例[J].中国介入心脏病学杂志,2004,12(4):217-217. 被引量:10
  • 8Brodie BR,Cooper C,Jones M,et al.Is adjunctive balloon post -dilatation necessary after coronary stent deployment? Final results from the POSTIT trial.Catheter Cardiovasc Interv,2003,59:184-192.
  • 9Cheneau E,Satler LF,Escolar E,et al.Underexpansion of sirolimus-eluting stents:Incidence and relationship to delivery pressure.Catheter Cardiovasc Interven,2005,65:222-226.
  • 10韩雅玲,梁明,荆全民,王守力,马颖艳,栾波.52例冠状动脉支架内血栓形成患者的临床特点及介入治疗[J].中华心血管病杂志,2006,34(11):975-978. 被引量:34

二级参考文献40

  • 1韩雅玲,王守力,李毅,荆全民,马颖艳,王祖禄,王冬梅,栾波,王效增.急性冠状动脉综合征患者冠状动脉支架术前高负荷量氯吡格雷预治疗近期疗效[J].中国介入心脏病学杂志,2005,13(1):9-12. 被引量:53
  • 2张俊杰,陈淮沁,李志恒,林延庭,陈绍良.比较Cypher^(TM)和Taxus^(TM)支架在冠心病合并糖尿病患者中应用的安全性和有效性[J].介入放射学杂志,2005,14(6):569-572. 被引量:2
  • 3胡健,张建盛,张奇,杨震坤,张瑞岩,张宪,沈卫峰.重叠药物洗脱支架术治疗冠状动脉长病变的临床疗效[J].介入放射学杂志,2006,15(2):67-69. 被引量:9
  • 4[1]Helgason CM, Bolion KM, Hoff JA, et al. Development of aspirin resistance in persons with previous ischemic stroke[J]. Stroke,1994,25:2331-2336.
  • 5[2]Hung J, Lam JY, Lacoste L, et al. Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin[J]. Circulation,1995, 92:2432-2436.
  • 6[3]Buchanan MR,Brister SJ. Individual variation in the effects of ASA on platelet function :implications for the use of ASA clinical[J]. Can J Cardiol,1995,11:221-227.
  • 7[4]Mueller MR, Salat A, Stangl P, et al. Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty[J]. Thromb Haemost,1997,78:1003-1007.
  • 8[5]Grotemeyer KH, Scharafinski HW, Husstedt IW. Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients[J]. Thromb Res,1993, 71:397-403.
  • 9[6]Leon MB, Baim DS, Popma JJ, et al. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators[J]. N Engl J Med,1998,339:1665-1671.
  • 10[7]Alexander JH, Harrington RA, Tuttle RH, et al. Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes. PURSUIT Investigators. Platelet Ⅱb/Ⅲa in Unstable angina: Receptor Suppression Using Integrilin Therapy[J]. Am J Cardiol,1999, 83:1147-1151.

共引文献55

同被引文献41

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部